OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
March 02, 2008
Quality-by-design submissions may reduce supplements and improve change management.
February 02, 2008
The rise in overseas manufacturing undermines FDA oversight of drug quality.
January 02, 2008
As FDA implements new drug-safety policies, manufacturers will focus on quality and pricing.
December 02, 2007
There are at least two major factors that will shape the manufacturing industry as a whole. Daniel Ruppar, Industry Manager (North America) for the Pharmaceuticals and Biotechnology Division of Frost & Sullivan predicts that, due to continued globalization, we can expect to see "growth centers for the industry move to emerging market sectors."
To keep up with applications, FDA promotes new testing and administrative methods.
November 02, 2007
New FDA act reshapes drug development and marketing to restore public trust in pharmaceutical regulation.